Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

Chemo vs HMAs and Venclexta Show Similar Survival Outcomes in AML

October 24th 2024, 3:00pm

Article

Adjusted survival outcomes were similar for patients with NPM1-mutated AML with intensive induction chemotherapy or hypomethylating agents and Venclexta.

My Acute Myeloid Leukemia Diagnosis at 22 Weeks Pregnant

October 14th 2024, 1:00pm

Article

During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of AML.

4 Years After My Bone Marrow Transplant for AML

October 4th 2024, 5:00pm

Article

As a survivor of acute myeloid leukemia, some things are no longer going to be normal, but who wants to be normal?

Several Resources I Counted on During Treatment for AML

September 16th 2024, 5:00pm

Article

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were available to me.

8 Things to Do While in the Hospital for Cancer Treatment

August 26th 2024, 5:00pm

Article

While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.

Less-Intense Chemotherapy May Be Preferrable in Older Patients with AML

August 14th 2024, 8:00pm

Article

Researchers compared health-related quality of life among patients ages 60 and older with acute myeloid leukemia undergoing different chemotherapy regimens.

Experiencing Loneliness as a Cancer Survivor

August 7th 2024, 5:00pm

Article

After receiving cancer treatment and leaving the hospital, sometimes it feels like a safety net has been pulled away and loneliness sets in.

Surviving Acute Myeloid Leukemia Has Finally Sunk In

June 26th 2024, 5:00pm

Article

Being able to live independently and enjoy life’s beauty summon feelings of gratitude and euphoria more often now.

Standard Treatment With Adjustments May Extend Survival in Older Patients With AML

May 28th 2024, 7:00pm

Article

Patients aged 80 and older are often excluded from receiving the standard regimen for acute myeloid leukemia. However, research showed that some patients can tolerate the therapy.

Ziftomenib Granted Breakthrough Therapy Designation by FDA in R/R AML

April 23rd 2024, 3:00pm

Article

The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute myeloid leukemia.